Skip to main content
Navigate Up
Sign In

University of Colorado Denver | Anschutz Medical Campus

University of Colorado Denver, Newsroom

Contact Info

Email Us >

Contact a Specialist >

Submit a Story >

For General Inquiries:

Call 303-724-1520
or Fax 303-724-1521

Address:

The Anschutz Medical Campus,
Building 500, Room CG009
13001 E. 17th Place
Mail Stop F413,
P.O. Box 6508
Aurora, CO 80045-0508

 

 Also of interest

 

Groundbreaking next step for bioscience partnership

Space to accommodate education, research and clinical care

4/4/2014
Chancellor Elliman speaking at the Bioscience groundbreaking
AURORA, Colo. - After seven years of talking about and planning the merger between the Fitzsimons Redevelopment Authority (FRA)  and CU's Bioengineering program, the physical collaboration is emerging.
 
(Photo above: Don Elliman at podium; Lilly Marks and Steve Hogan

An April 4 groundbreaking in Aurora for the new Bioscience 2 building was held on the Fitzsimons side of the Anschutz Medical Campus.
 
The group that gathered to turn the first shovels of dirt for the building project included dignitaries from CU, the FRA and the City of Aurora.
 
CU Vice President for Health Affairs and Executive Vice Chancellor of the Anschutz Medical Campus Lilly Marks welcomed the crowd noting the unique partnership this building will represent and the collaboration it brings to the campus merging the Bioscience Park and CU’s Bioengineering program. 
 
 
The building's design is multipurpose for education, research and clinical care. It reflects the concept: ‘from the research bench to the patient’s bedside.’ Bioscience 2 also adds another dimension to this mix: the added entrepreneurial element of private biosciences companies.
 
The new 112,000 square foot building will accommodate approximately 250 students and provide space for potential bioscience starter companies to grow.
 
Bioengineering students will have classes on the first two floors of the four-story building, and from there, the students will move up a floor and practice what they have learned and then move up again to begin their own commercial bioscience company on the top floor.
 
Steve VanNurden the president and CEO of the FRA, echoed excitement about the collaboration ,“this groundbreaking kicks off a new era of expansion for the Colorado Life Science District at Fitzsimons.”
 
CU Chancellor Don Elliman mentioned that two companies also will be housed there. They are Clinimmune, a company that banks umbilical cord blood and is growing out of its space in the FRA building, and 1C42, a testing company also currently in the FRA building.
 
Aurora Mayor Steve Hogan acknowledged the value of this partnership for research and education, as well as a benefit for his city.
 
Completion is scheduled for August 2015.
 
###

Share